Health Sciences Group, Inc.
HESG · OTC
9/30/2006 | 6/30/2006 | 3/31/2006 | 12/31/2005 | |
|---|---|---|---|---|
| Revenue | $5 | $8 | $20 | $36 |
| % Growth | -35% | -62.7% | -44% | – |
| Cost of Goods Sold | $3 | $6 | $15 | $28 |
| Gross Profit | $2 | $2 | $5 | $9 |
| % Margin | 34.9% | 27.1% | 26.3% | 23.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $722 | $1,209 | $0 | $1,192 |
| SG&A Expenses | $747 | $1,338 | $1,852 | $1,184 |
| Sales & Mktg Exp. | $25 | $128 | $0 | -$8 |
| Other Operating Expenses | $165 | -$2,838 | $169 | -$173 |
| Operating Expenses | $912 | -$1,500 | $2,020 | $1,011 |
| Operating Income | -$911 | $1,502 | -$2,015 | -$1,002 |
| % Margin | -18,430.1% | 19,742.4% | -9,891% | -2,754.4% |
| Other Income/Exp. Net | -$40 | -$2,670 | $350 | $1,002 |
| Pre-Tax Income | -$950 | -$1,168 | -$1,665 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$950 | -$1,168 | -$1,665 | $23 |
| % Margin | -19,219.1% | -15,352.3% | -8,173% | 63.2% |
| EPS | -0.03 | -0.04 | -0.06 | 0.001 |
| % Growth | 25% | 33.3% | -6,766.7% | – |
| EPS Diluted | -0.03 | -0.04 | -0.06 | 0.001 |
| Weighted Avg Shares Out | 39,690 | 33,224 | 28,322 | 24,626 |
| Weighted Avg Shares Out Dil | 39,690 | 33,224 | 28,322 | 24,626 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $109 | $136 | $183 | $1,013 |
| Depreciation & Amortization | $405 | $528 | $627 | $646 |
| EBITDA | -$506 | $2,030 | -$1,388 | -$356 |
| % Margin | -10,236.7% | 26,682.4% | -6,813.3% | -979.2% |